| Oscar Insurance Guidelines | Dupixent dupilumab | 2025-10-01 |
| Oscar Insurance Guidelines | Vemlidy tenofovir alafenamide | 2025-10-01 |
| Oscar Insurance Guidelines | rosuvastatin Crestor | 2025-10-01 |
| Oscar Insurance Guidelines | Omega-3-acid ethyl esters Lovaza | 2025-10-01 |
| BCBS Texas Medical Policies | Burosumab-twza | 2025-10-01 |
| BCBS Texas Medical Policies | Chromoendoscopy as an Adjunct to Colonoscopy | 2025-10-01 |
| BCBS Texas Medical Policies | Denosumab (Prolia & Xgeva) and Associated Biosimilars | 2025-10-01 |
| BCBS Texas Medical Policies | Gene Therapy for Inherited Retinal Dystrophy | 2025-10-01 |
| BCBS Texas Medical Policies | Infrared Therapy Devices | 2025-10-01 |
| BCBS Texas Medical Policies | Lanreotide | 2025-10-01 |